"What makes me optimistic, Victor, is particularly in my current role, all the conversations that I have with people in the community. Every day it's a different conversation. But it's always inspiring to me to hear from people about what it is that they're striving for. And for me to get an understanding of what I can do to help address some of the challenges.But everyone in the community wants to live well."
Researchers at The University of Queensland will progress toward a trial to see if a specialised dietary fibre supplement is safe for use in children with type 1 diabetes after positive results in adults. With the increase of type I diabetes in the last 50 years, growing evidence is showing that changes in gut bacteria may hold a secret to the triggering of the disease. By targeting the gut microbiome with specialised dietary fibre supplements, researchers hope to see a low-cost approach to prevention and glucose management. | https://medicine.uq.edu.au/article/2021/07/diabetes-research-challenging-paramount
Researchers at the University of Queensland and WEHI have identified a new generation anti-cancer drug that could be repurposed for aggressive childhood brain tumour, medulloblastoma. The international collaboration spent five years mapping the genetics of this common and fatal brain cancer for children. The existing drug has been approved for other diseases or cancers but never tested in paediatric brain tumours. Ixabepilone which is used to treat breast cancer, was found to block tumour growth and significantly extend survival rates in preclinical models. | https://www.uq.edu.au/news/node/129501